{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:11:26Z","timestamp":1790172686893,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejphar.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T03:32:52Z","timestamp":1493782372000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)"],"prefix":"10.1016","volume":"807","author":[{"given":"Sarah A.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi\u00a0Hooi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.D.","family":"Bathgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Akhter","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Huei","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.05.005_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/jhh.2011.29","article-title":"The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia","volume":"26","author":"Aggarwal","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ejphar.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/humupd\/dmw021","article-title":"G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin\/insulin-like family peptide receptor 1 for treatment and prevention","volume":"22","author":"Conrad","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ejphar.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1152\/japplphysiol.00545.2003","article-title":"Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats","volume":"95","author":"Danielson","year":"2003","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cardfail.2009.01.008","article-title":"Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial","volume":"15","author":"Dschietzig","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2017.05.005_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/cvr\/cvs149","article-title":"Relaxin improves TNF-\u03b1-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling","volume":"95","author":"Dschietzig","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2017.05.005_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cbpa.2014.09.014","article-title":"Synthetic relaxins","volume":"22","author":"Hossain","year":"2014","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib8","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1039\/C5SC04754D","article-title":"A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1","volume":"7","author":"Hossain","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejphar.2017.05.005_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1096\/fj.13-233429","article-title":"Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment","volume":"28","author":"Jelinic","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2017.05.005_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000104086.43830.6C","article-title":"Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries","volume":"93","author":"Jeyabalan","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2017.05.005_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/en.2006-0989","article-title":"Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin","volume":"148","author":"Jeyabalan","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2017.05.005_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2016.06.025","article-title":"Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries","volume":"111","author":"Kahlberg","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2017.05.005_bib13","doi-asserted-by":"crossref","first-page":"e107382","DOI":"10.1371\/journal.pone.0107382","article-title":"A vasoactive role for endogenous relaxin in mesenteric arteries of male mice","volume":"9","author":"Leo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejphar.2017.05.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.113.000493","article-title":"Acute intravenous injection of serelaxin (recombinant human relaxin\u20102) causes rapid and sustained bradykinin\u2010mediated vasorelaxation","volume":"3","author":"Leo","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2017.05.005_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tips.2016.04.001","article-title":"Serelaxin: a novel therapeutic for vascular diseases","volume":"37","author":"Leo","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.05.005_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/bph.13404","article-title":"Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)","volume":"173","author":"Leo","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2017.00141","article-title":"Serelaxin treatment reduces oxidative stress and increases aldehyde dehydrogenase-2 to attenuate nitrate tolerance","volume":"8","author":"Leo","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/bph.13614","article-title":"Vascular actions of relaxin: nitric oxide and beyond","volume":"174","author":"Leo","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib19","doi-asserted-by":"crossref","first-page":"R847","DOI":"10.1152\/ajpregu.00506.2015","article-title":"Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice","volume":"310","author":"Marshall","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/biolre\/iox023","article-title":"Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction","author":"Marshall","year":"2017","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2017.05.005_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1933719116657189","article-title":"The role of relaxin in normal and abnormal uterine function during the menstrual cycle and early pregnancy","volume":"24","author":"Marshall","year":"2017","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejphar.2017.05.005_bib22","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1113\/jphysiol.2012.230011","article-title":"Uteroplacental insufficiency programmes vascular dysfunction in non-pregnant rats: compensatory adaptations in pregnancy","volume":"590","author":"Mazzuca","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.phrs.2016.03.011","article-title":"Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta","volume":"107","author":"Ng","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2017.05.005_bib24","doi-asserted-by":"crossref","first-page":"39604","DOI":"10.1038\/srep39604","article-title":"Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes","volume":"9","author":"Ng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2017.05.005_bib25","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1152\/ajpregu.00635.2001","article-title":"Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats","volume":"283","author":"Novak","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib26","doi-asserted-by":"crossref","DOI":"10.1096\/fj.06-6263com","article-title":"Evidence for local relaxin ligand-receptor expression and function in arteries","volume":"20","author":"Novak","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2017.05.005_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/eurheartj\/eht459","article-title":"A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure","volume":"35","author":"Ponikowski","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2017.05.005_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bph.13371","article-title":"Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells","volume":"173","author":"Sarwar","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/FJC.0000000000000348","article-title":"Diverse functions of endothelial NO synthases system: NO and EDH","volume":"67","author":"Shimokawa","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.05.005_bib30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2017.05.005_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.peptides.2013.08.020","article-title":"Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats","volume":"49","author":"van Drongelen","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2017.05.005_bib32","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1096\/fj.12-210567","article-title":"Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow","volume":"26","author":"Vodstrcil","year":"2012","journal-title":"FASEB J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917303059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T01:26:36Z","timestamp":1535851596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917303059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"alternative-id":["S0014299917303059"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}